APP and Alzheimer disease: Additional confirmation of an involvement of IGF-IR in AD-like pathology was obtained using a homozygous neuronal-only tamoxifen-regulated IGF-IR KO mouse bred in an APP/PS1 background (Gontieret al., 2015).